The Research Chemical α-Methyltryptamine (αMT) is tryptamine with a methyl substituent at the alpha carbon. Its chemical relation to tryptamine is analogous to that of amphetamine to phenethylamine, amphetamine being α-methylphenethylamine. αMT is closely related to the neurotransmitter serotonin (5-hydroxytryptamine) which partially explains its mechanism of action.

Synthacaine is also known as Synthecaine and is similar to dimethocaine but with slight stimulant properties.

The Research Chemical 3-diethylamino-2,2-dimethylpropyl)-4-aminobenzoate. Dimethocaine, also known as larocaine, is a local anesthetic with slight stimulant properties that some studies show to be nearly as potent as cocaine.

Ethylphenidate (EP) is a potent psychostimulant that acts as both a dopamine reuptake inhibitor and norepinephrine reuptake inhibitor, meaning it effectively boosts the levels of the norepinephrine and dopamine neurotransmitters in the brain, by binding to, and partially blocking the transporter proteins that normally remove those monoamines from the synaptic cleft.

α-Methyltryptamine (αMT, AMT, Indopan), is a psychedelic, stimulant, and entactogen of the tryptamine class.[2][3] It was originally developed as an antidepressant by workers at Upjohn in the 1960s.

Methiopropamine (MPA) is a thiophene-based structural analog of methamphetamine originally reported in 1942.[1] It originally appeared for public sale in the UK in December 2010[2][3] as a research chemical.

The full name of the chemical is N-allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1-amine. It is chemically related to the compounds 5-MeO-DPT and DALT.

Synthacaine is also known as Synthecaine and is similar to dimethocaine but with slight stimulant properties.

The Research Chemical Methiopropamine is a thiophene-based structural analog of methamphetamine originally reported in 1942.

The Research Chemical 3-diethylamino-2,2-dimethylpropyl)-4-aminobenzoate. Dimethocaine, also known as larocaine, is a local anesthetic with slight stimulant properties that some studies show to be nearly as potent as cocaine.

Ethylphenidate (EP) is a potent psychostimulant that acts as both a dopamine reuptake inhibitor and norepinephrine reuptake inhibitor, meaning it effectively boosts the levels of the norepinephrine and dopamine neurotransmitters in the brain, by binding to, and partially blocking the transporter proteins that normally remove those monoamines from the synaptic cleft.

The Research Chemical 5,6-Methylenedioxy-2-aminoindane (MDAI) is a chemical developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a non-neurotoxic and highly selective serotonin releasing agent (SSRA) in vitro and produces mild entactogen effects in humans.

The name of this research material is 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine. Etizolam belongs to a class of research materials known as benzodiazepines which act as positive allosteric modulators of the GABA_a receptor. Etizolam is designed for both cellular and animal models.